Product Information

IMATINIB MESYLATE 100 MG TAB is a generic product labeled by American Health Packaging, priced at $0.6688 per EA under NDC 60687088221. Its NADAC has been published 87 times since Mar 26, 2025.

FDA first approved this application on Aug 5, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Imatinib Mesylate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

IMATINIB MESYLATE 100 MG TAB

Imatinib Mesylate
$0.6688per EA
Low Outlier

Strength

100 mg/1

NDC

60687088221

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA079179

FDA Approved

8/5/2016

TE Code

AB

On Market Since

2/19/2025

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price Statistics

The NADAC for IMATINIB MESYLATE 100 MG TAB has been published 87 times since Mar 26, 2025, and over the history we have for it it has declined 8.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6688 per EA
All-time high$0.9761 (Sep 10, 2025)
All-time low$0.6114 (Aug 19, 2026)
52-week high$0.8736
52-week low$0.6114
Median price$0.8271
Average price$0.8048
Largest weekly change+13.2% (Apr 23, 2025)
Weeks tracked87
Tracking sinceMar 26, 2025

Price History

1W

+3.8%

1M

+7.1%

3M

+9.4%

6M

-9.7%

1Y

-22.6%

3Y

N/A

5Y

N/A

All

-8.0%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of IMATINIB MESYLATE 100 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 100 MG TAB, manufactured by American Health Packaging, is $0.6688 per EA (NDC 60687088221), effective Nov 18, 2026.

How has the price of IMATINIB MESYLATE 100 MG TAB changed over time?

Over the history we have for it, the NADAC for IMATINIB MESYLATE 100 MG TAB has declined 8.0%. It has been tracked across 87 weekly CMS publications since Mar 26, 2025.

What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 100 MG TAB?

Since Mar 26, 2025, the NADAC for IMATINIB MESYLATE 100 MG TAB has ranged from a low of $0.6114 (Aug 19, 2026) to a high of $0.9761 (Sep 10, 2025), with a median of $0.8271 per EA.

Are there cheaper alternatives to IMATINIB MESYLATE 100 MG TAB?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IMATINIB MESYLATE 100 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures IMATINIB MESYLATE 100 MG TAB?

IMATINIB MESYLATE 100 MG TAB (NDC 60687088221) is labeled by American Health Packaging, and CMS classifies it as a generic product.